PMID- 28618428 OWN - NLM STAT- MEDLINE DCOM- 20170804 LR - 20190212 IS - 1421-9778 (Electronic) IS - 1015-8987 (Linking) VI - 42 IP - 2 DP - 2017 TI - The Impact of Circulating Mitochondrial DNA on Cardiomyocyte Apoptosis and Myocardial Injury After TLR4 Activation in Experimental Autoimmune Myocarditis. PG - 713-728 LID - 10.1159/000477889 [doi] AB - BACKGROUND/AIMS: Mitochondrial DNA (mtDNA), acting as a newly found 'danger-associated molecular patterns' (DAMPs), is released into circulation upon tissue injury and performs as a considerable activator of inflammation and immune response. However, the role of circulating mtDNA in experimental autoimmune myocarditis (EAM) as well as Toll like receptor4 (TLR4) mediated cardiac inflammation and injury remains unknown. METHODS: A model of EAM was established in BALB/c mice by immunization with porcine cardiac myosin. Lipopolysaccharide (LPS) was used to stimulate TLR4 activation in EAM mice and H9C2 cells. RESULTS: LPS stimulation significantly aggravated cardiac inflammation and tissue injury in EAM, as demonstrated by increased myocardium inflammatory cell infiltration, and up-regulated inflammatory cytokines and troponin I(TnI) level in serum. Circulating mtDNA level was increased in EAM and TLR4 activation led to a greater elevation, which may be related to Reactive oxygen species (ROS) stress involved mtDNA damage characterized by reduced mtDNA copy number in myocardium tissue. In addition, the expression of Toll like receptor9 (TLR9), a ligand of mtDNA, was significantly up-regulated in the myocardium of EAM and EAM LPS group; meanwhile, TLR9 inhibition by ODN 2088 caused an inhibited apoptosis in LPS treated H9C2 cells. Moreover, in EAM and EAM LPS group, simultaneously giving ODN 2088 treatment significantly ameliorated cardiac inflammation and tissue injury compared with untreated group. CONCLUSION: Increased circulating mtDNA combined with upregulated TLR9 expression may corporately play a role in EAM as well as TLR4 activation mediated cardiac inflammation and injury. CI - (c) 2017 The Author(s). Published by S. Karger AG, Basel. FAU - Wu, Bangwei AU - Wu B FAU - Ni, Huanchun AU - Ni H FAU - Li, Jian AU - Li J FAU - Zhuang, Xinyu AU - Zhuang X FAU - Zhang, Jinjin AU - Zhang J FAU - Qi, Zhiyong AU - Qi Z FAU - Chen, Qiying AU - Chen Q FAU - Wen, Zhichao AU - Wen Z FAU - Shi, Haiming AU - Shi H FAU - Luo, Xinping AU - Luo X FAU - Jin, Bo AU - Jin B LA - eng PT - Journal Article DEP - 20170615 PL - Germany TA - Cell Physiol Biochem JT - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology JID - 9113221 RN - 0 (DNA, Mitochondrial) RN - 0 (Lipopolysaccharides) RN - 0 (Reactive Oxygen Species) RN - 0 (Tlr4 protein, mouse) RN - 0 (Tlr9 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 0 (Toll-Like Receptor 9) RN - 0 (Troponin I) SB - IM MH - Animals MH - Apoptosis/genetics MH - Autoimmune Diseases/*blood/chemically induced/genetics/pathology MH - DNA, Mitochondrial/*blood MH - Disease Models, Animal MH - Gene Expression Regulation MH - Heart Injuries/blood/genetics/pathology MH - Humans MH - Inflammation/blood/genetics/pathology MH - Lipopolysaccharides/toxicity MH - Mice MH - Myocarditis/*blood/chemically induced/genetics/pathology MH - Myocardium/metabolism/pathology MH - Myocytes, Cardiac/metabolism/pathology MH - Reactive Oxygen Species/metabolism MH - Toll-Like Receptor 4/*biosynthesis/genetics MH - Toll-Like Receptor 9/*biosynthesis/genetics MH - Troponin I/blood OTO - NOTNLM OT - Circulating mtDNA OT - EAM OT - ROS stress OT - TLR4 OT - TLR9 EDAT- 2017/06/16 06:00 MHDA- 2017/08/05 06:00 CRDT- 2017/06/16 06:00 PHST- 2016/12/01 00:00 [received] PHST- 2017/04/13 00:00 [accepted] PHST- 2017/06/16 06:00 [pubmed] PHST- 2017/08/05 06:00 [medline] PHST- 2017/06/16 06:00 [entrez] AID - 000477889 [pii] AID - 10.1159/000477889 [doi] PST - ppublish SO - Cell Physiol Biochem. 2017;42(2):713-728. doi: 10.1159/000477889. Epub 2017 Jun 15.